QQ客服 官方微博 反馈留言

浏览/检索结果: 共4条，第1-4条 帮助 限定条件 内容类型：会议论文     已选(0)清除 条数/页：5101520253035404550556065707580859095100   排序方式：请选择作者升序作者降序题名升序题名降序发表日期升序发表日期降序提交时间升序提交时间降序 Phase III study of afatinib vs placebo as adjuvant therapy after chemo-radiotherapy (CRT) in primary unresected patients with locoregionally advanced (LA) head and neck squamous cell carcinoma (HNSCC) in Asia: LUX-Head & Neck 4 (LUX-H&N4) 会议论文 作者:  Hu, C. S.;  Chan, A.;  Gao, L.;  Ahn, M. -J.;  Cohen, E. 收藏  |  浏览/下载：6/0  |  提交时间：2019/12/13 Phase III study of afatinib vs methotrexate (MTX) for second-line recurrent and/or metastatic (R/M) head and neck squamous cell carcinoma (HNSCC) patients after platinum-based chemotherapy (CT) in Asia/Middle East/North Africa: LUX-Head & Neck 3 (LUX-H&N3) 会议论文 作者:  Tang, P. Z.;  Ahn, M. -J.;  Zhang, Q.;  Chan, A.;  Kim, S. -B. 收藏  |  浏览/下载：2/0  |  提交时间：2019/12/19 Phase III study of afatinib vs methotrexate (MTX) for second-line recurrent and/or metastatic (R/M) head and neck squamous cell carcinoma (HNSCC) patients after platinum-based chemotherapy (CT) in Asia/Middle East/North Africa: LUX-Head & Neck 3 会议论文 ANNALS OF ONCOLOGY, 2015-12-01 作者:  Tang, P. Z.;  Ahn, M.J.;  Zhang, Q.;  Chan, A.;  Kim, S.B. 收藏  |  浏览/下载：6/0  |  提交时间：2020/01/04 Phase III study of afatinib vs placebo as adjuvant therapy after chemo-radiotherapy (CRT) in primary unresected patients with locoregionally advanced (LA) head and neck squamous cell carcinoma (HNSCC) in Asia: LUX-Head & Neck 4 (LUX-H&N4) 会议论文 ANNALS OF ONCOLOGY, 2015-12-01 作者:  Hu, C. S.;  Chan, A.;  Gao, L.;  Ahn, M.J.;  Cohen, E. 收藏  |  浏览/下载：4/0  |  提交时间：2020/01/04